Margaret G. Mcglynn

Director at Novavax · 3 reported transactions in 2 companies · latest report Jun 20, 2026

Their trades


NovavaxNVAX	Exercised options — · 18,880 shares	Jun 20, 2026
NovavaxNVAX	Exercised options — · 10,420 shares	Jun 12, 2025
Amicus TherapeuticsFOLD	Share award — · 20,414 shares	Jun 5, 2025

Exercised optionsNovavax

Jun 20, 2026 · NVAX

18,880

Exercised optionsNovavax

Jun 12, 2025 · NVAX

10,420

Share awardAmicus Therapeutics

Jun 5, 2025 · FOLD

20,414

3 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.